Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,450.00    -50.00 (-0.91%)
Bid:
5,400.00
Ask:
5,450.00
Spread: 50.00 (0.926%)
Market Cap: £137.76m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Update on BF&M Transaction

28 Jun 2024 13:00

RNS Number : 3659U
Camellia PLC
28 June 2024
 

28 June 2024

Camellia Plc

(the "Company" or the "Group")

 

Update on BF&M Transaction and change of name of Nominated Adviser

 

Update on BF&M Transaction

 

Further to the most recent update on the disposal of the Company's 36.9% shareholding in BF&M to Argus Group provided in our trading update on 6 June 2024, BF&M Limited ("BF&M") and Argus Group Holdings Limited ("Argus") announced today that the two companies plan to amalgamate (pursuant to Bermuda law), subject to receipt of appropriate shareholder and regulatory approvals (the "Amalgamation"). 

 

This announcement by BF&M and Argus establishes a way forward for regulatory approval of the sale of Camellia's holding of BF&M shares to Argus (the "Sale"). The Amalgamation is expected to take place after the completion of the Sale and special general meetings of BF&M and Argus. As previously announced, we expect the completion of the Sale will take place in the latter part of 2024.

 

To facilitate the timely completion of the Sale and the Amalgamation, Camellia and Argus have agreed that up to $50 million of the agreed $100 million consideration payable to Camellia for the BF&M shares may be deferred in the form of interest-bearing loan notes with a maximum one year term. The Sale is conditional on regulatory approvals and Argus financing. Any loan notes issued will be secured by a pledge over the shares of the buyer and a guarantee from Argus prior to the Amalgamation and, following completion of the Amalgamation, guaranteed by BF&M, the ultimate parent company of the amalgamated entity. If any of the consideration is deferred, Argus will be incentivised to pay down the loan quickly. The Company will provide further updates as appropriate.

 

Change of name of Nominated Advisor

 

The Company announces that its Nominated Adviser and Broker has changed its name to Panmure Liberum Limited following completion of its own corporate merger.

 

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

Enquiries

 

Camellia Plc 01622 746655

Byron Coombs, Chief Executive Officer

Oliver Capon, Chief Financial Officer

 

Panmure Liberum 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

 

H/Advisors Maitland 

PR

William Clutterbuck 07785 292617

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEANKPAFNLEEA
Date   Source Headline
19th Jun 20134:25 pmRNSTransaction in Own Shares
18th Jun 20134:32 pmRNSTransaction in Own Shares
17th Jun 20134:39 pmRNSTransaction in Own Shares
14th Jun 20135:16 pmRNSNotification of Major Interest in Shares
14th Jun 20134:33 pmRNSTransaction in Own Shares
14th Jun 20131:22 pmRNSNotification of Major Interest in Shares
12th Jun 20135:22 pmRNSTransaction in Own Shares
11th Jun 20134:28 pmRNSTransaction in Own Shares - Replacement
11th Jun 201310:45 amRNSTransaction in Own Shares
7th Jun 201310:21 amRNSResult of AGM
7th Jun 201310:12 amRNSRe Joint Venture
6th Jun 201312:30 pmRNSAGM Statement
28th Mar 20137:00 amRNSInterim Management Statement
7th Mar 201312:58 pmRNSDirectorate Change
20th Feb 20132:10 pmRNSNotification of Major Interest in Shares
5th Feb 20133:07 pmRNSNotification of Major Interest in Shares
4th Feb 20132:30 pmRNSNotification of Major Interest in Shares
8th Jan 20131:46 pmRNSDirectorate Change
3rd Jan 201311:16 amRNSDirector/PDMR Shareholding
26th Oct 20123:09 pmRNSRevised Interim Management Statement
26th Oct 20127:00 amRNSInterim Management Statement
3rd Sep 20124:47 pmRNSHalf Yearly Report
30th Aug 20127:00 amRNSHalf Yearly Report
8th Jun 201212:13 pmRNSResult of AGM
7th Jun 201212:17 pmRNSAGM Statement
1st Jun 20129:48 amRNSAnnual Information Update
3rd May 201211:21 amRNSAnnual Report 2011, notice of meeting, proxy form
26th Apr 201212:30 pmRNSFinal Results
30th Mar 20127:00 amRNSInterim Management Statement
26th Oct 20117:00 amRNSInterim Management Statement
8th Sep 201112:44 pmRNSCompany Secretary Change
5th Sep 201111:15 amRNSHalf Yearly Report
25th Aug 201112:00 pmRNSHalf Yearly Report
10th Jun 20112:00 pmRNSResult of AGM
9th Jun 201112:24 pmRNSAGM Statement
2nd Jun 20114:25 pmRNSAnnual Information Update
11th May 20113:27 pmRNSAnnual Report 2010, notice of meeting, proxy form
5th May 20111:12 pmRNSDisposal
28th Apr 201112:47 pmRNSAnnual Financial Report
30th Mar 201112:06 pmRNSInterim Management Statement
11th Jan 20114:35 pmRNSPrice Monitoring Extension
27th Oct 20103:16 pmRNSInterim Management Statement
7th Oct 201010:40 amRNSDisposal
8th Sep 20101:42 pmRNSDisposal
3rd Sep 20103:57 pmRNSDoc re. Interim Report 2010
26th Aug 20109:58 amRNSHalf Yearly Report
7th Jun 201010:46 amRNSResult of AGM
3rd Jun 201012:33 pmRNSAGM Statement
2nd Jun 201010:22 amRNSAnnual Information Update
6th May 20104:06 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.